4//SEC Filing
VERTEX PHARMACEUTICALS INC / MA 4
Accession 0001209191-12-042654
$VRTXCIK 0000875320operating
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 5:20 PM ET
Size
9.0 KB
Accession
0001209191-12-042654
Insider Transaction Report
Form 4
Kelly Lisa
SVP, Human Resources
Transactions
- Exercise/Conversion
Common Stock
2012-08-16$32.16/sh+953$30,648→ 18,202 total - Exercise/Conversion
Employee Stock Option (right to buy)
2012-08-16−953→ 954 totalExercise: $32.16Exp: 2018-07-23→ Common Stock (953 underlying) - Sale
Common Stock
2012-08-16$55.00/sh−953$52,415→ 17,249 total
Holdings
- 1,957(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1.
- [F2]Fully vested.
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeoperating
IncorporatedMA
Related Parties
1- filerCIK 0000875320
Filing Metadata
- Form type
- 4
- Filed
- Aug 19, 8:00 PM ET
- Accepted
- Aug 20, 5:20 PM ET
- Size
- 9.0 KB